164 related articles for article (PubMed ID: 11418634)
21. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation.
Shi Z; Silveira A; Patel P; Feng X
Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837
[TBL] [Abstract][Full Text] [Related]
22. IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes.
Patten M; Wang W; Aminololama-Shakeri S; Burson M; Long CS
J Mol Cell Cardiol; 2000 Jul; 32(7):1341-52. PubMed ID: 10860774
[TBL] [Abstract][Full Text] [Related]
23. Posttranscriptional inhibition of gene expression by Mycobacterium tuberculosis offsets transcriptional synergism with IFN-gamma and posttranscriptional up-regulation by IFN-gamma.
Qiao Y; Prabhakar S; Canova A; Hoshino Y; Weiden M; Pine R
J Immunol; 2004 Mar; 172(5):2935-43. PubMed ID: 14978096
[TBL] [Abstract][Full Text] [Related]
24. E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
Crowe DL; Nguyen DC; Tsang KJ; Kyo S
Nucleic Acids Res; 2001 Jul; 29(13):2789-94. PubMed ID: 11433024
[TBL] [Abstract][Full Text] [Related]
25. Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide.
Hara H; Adachi T
Mol Pharmacol; 2002 Jan; 61(1):194-200. PubMed ID: 11752221
[TBL] [Abstract][Full Text] [Related]
26. Bcl6 is a transcriptional repressor for the IL-18 gene.
Takeda N; Arima M; Tsuruoka N; Okada S; Hatano M; Sakamoto A; Kohno Y; Tokuhisa T
J Immunol; 2003 Jul; 171(1):426-31. PubMed ID: 12817026
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
[TBL] [Abstract][Full Text] [Related]
28. YY1 transcription factor is not responsible for the negative regulation of hamster Muc1 transcription.
Hisatsune A; Hyun SW; Lee IJ; Georas S; Kim KC
Anticancer Res; 2004; 24(1):235-40. PubMed ID: 15015602
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT.
Fujimoto K; Kyo S; Takakura M; Kanaya T; Kitagawa Y; Itoh H; Takahashi M; Inoue M
Nucleic Acids Res; 2000 Jul; 28(13):2557-62. PubMed ID: 10871406
[TBL] [Abstract][Full Text] [Related]
30. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma.
Saito H; Morita Y; Fujimoto M; Narazaki M; Naka T; Kishimoto T
J Immunol; 2000 Jun; 164(11):5833-43. PubMed ID: 10820262
[TBL] [Abstract][Full Text] [Related]
31. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
Raval-Pandya M; Dhawan P; Barletta F; Christakos S
Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120
[TBL] [Abstract][Full Text] [Related]
32. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells.
Tripathi MK; Misra S; Khedkar SV; Hamilton N; Irvin-Wilson C; Sharan C; Sealy L; Chaudhuri G
J Biol Chem; 2005 Apr; 280(17):17163-71. PubMed ID: 15734731
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Delgado M; Ganea D
J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
[TBL] [Abstract][Full Text] [Related]
35. An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression.
Malone CS; Patrone L; Buchanan KL; Webb CF; Wall R
J Immunol; 2000 Mar; 164(5):2550-6. PubMed ID: 10679093
[TBL] [Abstract][Full Text] [Related]
36. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
[TBL] [Abstract][Full Text] [Related]
37. CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter.
Mikheev AM; Mikheev SA; Zhang Y; Aebersold R; Zarbl H
Nucleic Acids Res; 2000 Oct; 28(19):3762-70. PubMed ID: 11000268
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
39. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
Weisz A; Cicatiello L; Esumi H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
